Search Within

Neha Sanat Korde

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (77)
  2. Journal Article (22)
  3. Research Letter (4)
  4. Correspondence (2)
Groups
  1. Biostatistics Service (105)
  2. Center for Hematologic Malignancies (105)
  3. Department of Medicine (105)
  4. Epidemiology and Biostatistics (105)
  5. Hematologic Malignancies, Division of (105)
  6. Myeloma (105)

More Groups

People
  1. Alexander Lesokhin (104)
  2. Hani Hassoun (103)
  3. Sham Mailankody (99)
  4. Sergio Giralt (94)
  5. Heather Landau (90)
  6. David Chung (89)

More People

Years
  1. 2025 (2)
  2. 2024 (15)
  3. 2023 (22)
  4. 2022 (22)
  5. 2021 (11)
  6. 2020 (8)

More Years

Publications
  1. Blood (40)
  2. Clinical Lymphoma, Myeloma and Leukemia (26)
  3. Journal of Clinical Oncology (8)
  4. Leukemia and Lymphoma (6)
  5. Biology of Blood and Marrow Transplantation (5)
  6. Blood Cancer Journal (5)

More Publications

Publishers
  1. American Society of Hematology (41)
  2. Elsevier Inc. (32)
  3. American Society of Clinical Oncology (8)
  4. Nature Publishing Group (7)
  5. Taylor & Francis Group (6)
  6. Ferrata Storti Foundation (3)

More Publishers

Results (105)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and efficacy of re-immunization with inactivated vaccines in multiple myeloma patients on lenalidomide maintenance following autologous hematopoietic stem cell transplantation (auto HCT)
    Meeting Abstract

    Palazzo, M.; Shah, G. L.; Copelan, O.; Seier, K.; Devlin, S. M.; Hassoun, H.; Korde, N. S.; Lendvai, N.; Lesokhin, A. M.; Mailankody, S.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • MRD response-driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone
    Meeting Abstract

    Korde, N.; Mailankody, S.; Smith, E. L.; Lendvai, N.; Hassoun, H.; Lesokhin, A.; Hultcrantz, M.; Chung, D. J.; Shah, G. L.; Koehne, G.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Galinpepimut-S, a WT1-targeting immuno-oncology treatment, induces specific, robust and durable immune responses (IRs) in patients (Pts) with high-risk (HR) multiple myeloma (MM)
    Meeting Abstract

    Koehne, G.; Devlin, S.; Korde, N.; Mailankody, S.; Heather, L.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Chung, D.; Sarlis, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving lenalidomide maintenance
    Journal Article

    Hassoun, H.; Roshal, M.; Sabari, J.; Nguyen, J.; Gao, Q.; Devlin, S. M.; Landau, H.; Lendvai, N.; Chung, D. J.; Lesokhin, A. M.; more...
    Leukemia and Lymphoma (2017)

    Fulltext@MSK | Save
  • WT1 heteroclitic epitope immunization following autologous stem cell transplantation in patients with high-risk multiple myeloma (MM)
    Meeting Abstract

    Koehne, G.; Devlin, S.; Chung, D.; Landau, H.; Korde, N.; Mailankody, S.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Giralt, S.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • Re-immunization following autologous hematopoietic stem cell transplantation (Auto HCT) is safe and effective in patients with multiple myeloma receiving lenalidomide maintenance
    Meeting Abstract

    Shah, G.; Palazzo, M.; Copelan, O.; Seier, K.; Devlin, S.; Hassoun, H.; Korde, N.; Lendvai, N.; Lesokhin, A.; Mailankody, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Improvement of response for multiple myeloma patients on lenalidomide maintenance after autologous hematopoietic stem cell transplantation (Auto HCT)
    Meeting Abstract

    Shah, G.; Assal, A.; Hsu, M.; Devlin, S.; Hassoun, H.; Korde, N.; Lendvai, N.; Lesokhin, A.; Mailankody, S.; Smith, E.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Proteomic profiling in plasma cell disorders: A feasibility study
    Journal Article

    Mailankody, S.; Devlin, S. M.; Korde, N.; Lendvai, N.; Lesokhin, A.; Landau, H.; Hassoun, H.; Ballagi, A.; Ekman, D.; Chung, D. J.; more...
    Leukemia and Lymphoma (2017)

    Fulltext@MSK | Save
  • Comparison of standard assays (serum immunofixation and protein electrophoresis) with Hevylite assay in patients with multiple myeloma
    Meeting Abstract

    Hassoun, H.; Ruiz, R.; Kazunori, M.; Azzi, K.; Devlin, S.; Cooper, B.; Lendvai, N.; Landau, H.; Lesokhin, A. M.; Chung, D. J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma
    Journal Article

    Lendvai, N.; Yee, A. J.; Tsakos, I.; Alexander, A.; Devlin, S. M.; Hassoun, H.; Korde, N.; Lesokhin, A. M.; Landau, H.; Mailankody, S.; more...
    Blood (2016)

    Fulltext@MSK | Save